---
category: news
title: "Tonix Pharmaceuticals Initiates Phase 1 Trial of TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers"
excerpt: "Relative to tianeptine, estianeptine lacks activity on the µ-opioid receptor while maintaining activity in the rat Novel Object Recognition test in vivo and the ability to activate PPAR-β/δ and neuroplasticity in tissue culture. TNX-1900 (intranasal ..."
publishedDateTime: 2023-08-16T07:00:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/tonix-pharmaceuticals-initiates-phase-1-trial-of-tnx-1500-fc-modified-humanized-anti-cd40l-mab-in-healthy-volunteers-1032559209"
webUrl: "https://markets.businessinsider.com/news/stocks/tonix-pharmaceuticals-initiates-phase-1-trial-of-tnx-1500-fc-modified-humanized-anti-cd40l-mab-in-healthy-volunteers-1032559209"
type: article
quality: 10
heat: 10
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Computer Vision
  - AI

secured: "FRDC30pjUhf9O00ZLs3WGxIFf/8KXuoKl5fPpwjuKvO7yhscrSOfnr06yGoDCQqMFq4CWr6DFGnruFe3KcQxqOGQH/egDgzRsR4jh0R5+Lx1VE/6rNRknlpcIh/HNgVgbHpLLKjywpJ4bRrpm6vD95S0I/U729xYaSxBtsdUtLMvWoOfOedLNC0b7D0PVhYm177wrcrYuO6OyDzN9s5lvRdFd7f9eQ4urGmoKe0063dG0qf2tQw2rYj8Q8tsuslklyRsiEjHS5e93RQubJnmrnDBdsijaKRbdyhEW0MP6cztzM13TbQz0iVQojOCAINixoR4rwreiDiew0RlDYYm9kaBfinv56D27gc+QstXdNw=;qbvK5ndsPXANEJU8Bf+znQ=="
---

